Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

Market Cap	175.84M -31.6%
Revenue (ttm)	255.42M +4.1%
Net Income	15.06M -23.8%
EPS	1.08 -23.9%
Shares Out	13.90M
PE Ratio	11.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	12.90
Previous Close	12.65
Day's Range	12.65 - 12.90
52-Week Range	11.50 - 24.90
Beta	0.08
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About NSE:NIDAN

Nidan Laboratories and Healthcare Limited provides healthcare and diagnostic services in India. It offers diagnostic services, including pathology, radiology, cardiology, and neurology services. The company also engages in manufacturing and marketing of pharmaceuticals and active ingredients, as well as operates hospital chains, insurance companies, and diagnostic outfits. The company was founded in 1994 and is headquartered in Palghar, India.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 149
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NIDAN

Financial Performance

In fiscal year 2026, NSE:NIDAN's revenue was 255.42 million, an increase of 4.13% compared to the previous year's 245.28 million. Earnings were 15.06 million, a decrease of -23.82%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error